secobarbital has been researched along with Hyaline Membrane Disease in 1 studies
Secobarbital: A barbiturate that is used as a sedative. Secobarbital is reported to have no anti-anxiety activity.
secobarbital : A member of the class of barbiturates that is barbituric acid in which the hydrogens at position 5 are substituted by prop-2-en-1-yl and pentan-2-yl groups.
Hyaline Membrane Disease: A respiratory distress syndrome in newborn infants, usually premature infants with insufficient PULMONARY SURFACTANTS. The disease is characterized by the formation of a HYALINE-like membrane lining the terminal respiratory airspaces (PULMONARY ALVEOLI) and subsequent collapse of the lung (PULMONARY ATELECTASIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Secobarbital is commonly used in these patients, but dosage guidelines to avoid prolonged sedation are not available." | 2.67 | Prolonged sedation associated with secobarbital in newborn infants receiving ventilatory support. ( Edwards, RC; Nahata, MC; Starling, S, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nahata, MC | 1 |
| Starling, S | 1 |
| Edwards, RC | 1 |
1 trial available for secobarbital and Hyaline Membrane Disease
| Article | Year |
|---|---|
Prolonged sedation associated with secobarbital in newborn infants receiving ventilatory support.
Topics: Humans; Hyaline Membrane Disease; Infant, Newborn; Intensive Care, Neonatal; Persistent Fetal Circul | 1991 |